FDA Drug Application (022081) for LETAIRIS by GILEAD

Back to FDA Applications sponsored by GILEAD

Application Number022081
Product Number001
FormTABLET;ORAL
Dosage5MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameLETAIRIS
Active IngredientAMBRISENTAN



Back to FDA Applications sponsored by GILEAD